Office of the Director, National Institutes of Health; Notice of Meeting, 55708-55709 [2023-17576]

Download as PDF 55708 Federal Register / Vol. 88, No. 157 / Wednesday, August 16, 2023 / Notices amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; SBIR OMNIBUS. Date: September 20, 2023. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, National Center for Advancing Translational Sciences, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Rahat (Rani) Khan, Ph.D., Scientific Review Officer, Office of Scientific Review, National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1078, Bethesda, MD 20892, 301–594–7319, khanr2@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: August 10, 2023. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–17559 Filed 8–15–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health lotter on DSK11XQN23PROD with NOTICES1 National Heart, Lung, and Blood Institute; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Heart, Lung, and Blood Advisory Council. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocast VerDate Sep<11>2014 19:39 Aug 15, 2023 Jkt 259001 website https://www.nhlbi.nih.gov/ about/advisory-and-peer-reviewcommittees/advisory-council. Name of Committee: National Heart, Lung, and Blood Advisory Council. Date: September 12, 2023. Open: 9:00 a.m. to 12:00 p.m.; 3:00 p.m. to 5:00 p.m. Agenda: To discuss program policies and issues. Place: National Institutes of Health, Rockledge I, 6705 Rockledge Drive, Rockville, MD 20872. Videocast link: https://www.nhlbi.nih.gov/ about/advisory-and-peer-review-committees/ advisory-council. Contact Person: Laura K. Moen, Ph.D., Director, Division of Extramural Research Activities, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 206–Q, Bethesda, MD 20892, 301–827–5517, moenl@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors attending a meeting on campus or at an off-campus federal facility will be asked to show one form of identification (for example, a governmentissued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: www.nhlbi.nih.gov/meetings/nhlbac/ index.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: August 10, 2023. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–17560 Filed 8–15–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 amended, notice is hereby given of a meeting of the NIH Clinical Center Research Hospital Board. This will be a hybrid meeting held inperson and virtually and will be open to the public as indicated below. Individuals who plan to attend inperson or view the virtual meeting and need special assistance or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting can be accessed from the NIH Videocast at the following link: https:// videocast.nih.gov/. Name of Committee: NIH Clinical Center Research Hospital Board. Date: October 20, 2023. Time: 9:00 a.m. to 1:00 p.m. Agenda: NIH and Clinical Center (CC) Leadership Announcements, CC CEO Update of Recent Activities and Organizational Priorities, Status Report on Key CC Strategic Plan Initiatives, and Other Business of the Clinical Center Research Hospital Board (CCRHB). Place: National Institutes of Health, Building 31, Conference Room 6C02 A & B, 9000 Rockville Pike, Bethesda, MD 20892 (Hybrid Meeting). Contact Persons: Patricia Piringer, RN, MSN (C), National Institutes of Health Clinical Center, 10 Center Drive, Bethesda, MD 20892, ppiringer@ cc.nih.gov, (301) 402–2435, (202) 460–7542 (direct). Natascha Pointer, Management Analyst, Executive Assistant to Dr. Gilman, Office of the Chief Executive Officer, National Institutes of Health Clinical Center, 10 Center Drive, Bethesda, MD 20892, npointer@ cc.nih.gov, (301) 496–4114, (301) 402–2434 (direct). Any interested person may file written comments with the committee by forwarding the statement to the Contact Person(s) listed on this notice. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors attending a meeting on campus or at an off-campus federal facility will be asked to show one form of identification (for example, a governmentissued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the CCRHB website: https://www.ccrhb.od.nih.gov/ where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research E:\FR\FM\16AUN1.SGM 16AUN1 Federal Register / Vol. 88, No. 157 / Wednesday, August 16, 2023 / Notices Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: August 10, 2023. Patricia B. Hansberger, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2023–17576 Filed 8–15–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2023–0583] National Merchant Mariner Medical Advisory Committee; September 2023 Virtual Meetings U.S. Coast Guard, Department of Homeland Security. ACTION: Notice of Federal Advisory Committee virtual meeting. AGENCY: The National Merchant Mariner Medical Advisory Committee (Committee) will conduct virtual meetings over a series of 2 days to discuss matters relating to medical certification determinations for issuance of licenses, certificates of registry, and merchant mariners’ documents, medical standards, and guidelines for the physical qualifications of operators of commercial vessels, medical examiner education, and medical research. The Subcommittee on proposed Task Statement 23–X1—Directed Review of the Merchant Mariner Medical Manual will also meet on Day 1. These virtual meetings will be open to the public. DATES: Meetings: The Committee and one of its Subcommittees will meet virtually on Tuesday, September 12, 2023, from 10 a.m. until 3 p.m. Eastern Daylight Time, (EDT), and Wednesday, September 13, 2023, from 10 a.m. until 2:15 p.m. EDT. The virtual meetings may adjourn early if the Committee has completed its business. Comments and supporting documentation: To ensure your comments are received by Committee members before the virtual meetings, submit your written comments no later than September 5, 2023. ADDRESSES: To join the virtual meetings or to request special accommodations, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section no later than 1 p.m. EDT on September 5, 2023, to obtain the needed lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 19:39 Aug 15, 2023 Jkt 259001 information. The number of virtual lines is limited and will be available on a first-come, first-served basis. The Committee is committed to ensuring all participants have equal access regardless of disability status. If you require reasonable accommodation due to a disability to fully participate, please email Ms. Pamela Moore at pamela.j.moore@uscg.mil as soon as possible. Instructions: You are free to submit comments at any time, including orally at the virtual meetings as time permits, but if you want Committee members to review your comments before the virtual meetings, please submit your comments no later than September 5, 2023. We are particularly interested in comments on the topics in the ‘‘Agenda’’ section below. We encourage you to submit comments through the Federal eRulemaking Portal at https:// www.regulations.gov. If your material cannot be submitted using https:// www.regulations.gov, email the individual in the FOR FURTHER INFORMATION CONTACT section of this document for alternate instructions. You must include the docket number USCG– 2023–0583. Comments received will be posted without alteration at https:// www.regulations.gov, including any personal information provided. You may wish to review the Privacy and Security Notice found via link on the homepage of https:// www.regulations.gov. For more about privacy and submissions in response to this document, see DHS’s eRulemaking System of Records notice (85 FR 14226, March 11, 2020). If you encounter technical difficulties with comment submission, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this notice. Docket Search: Documents mentioned in this notice as being available in the docket, and all public comments, will be in our online docket at https:// www.regulations.gov and can be viewed by following that website’s instructions. Additionally, if you go to the online docket and sign-up for email alerts, you will be notified when comments are posted. FOR FURTHER INFORMATION CONTACT: Ms. Pamela Moore, Alternate Designated Federal Officer of the National Merchant Mariner Medical Advisory Committee, telephone 202–372–1361 or email pamela.j.moore@uscg.mil. SUPPLEMENTARY INFORMATION: Notice of these meetings is in compliance with the Federal Advisory Committee Act (Pub. L. 117–286, 5 U.S.C. ch. 10). The National Merchant Mariner Medical Advisory Committee is authorized by PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 55709 section 601 of the Frank LoBiondo Coast Guard Authorization Act of 2018 (Pub. L. 115–282, 132 Stat. 4192) and is codified in 46 U.S.C. 15104. The Committee operates under the provisions of the Federal Advisory Committee Act and 46 U.S.C section 15109. The Committee advises the Secretary of Homeland Security through the Commandant of the United States Coast Guard on matters relating to: (a) medical certification determinations for issuance of licenses, certificates of registry, and merchant mariners’ documents; (b) medical standards and guidelines for the physical qualifications of operators of commercial vessels; (c) medical examiner education; and (d) medical research. Agenda: The National Merchant Mariner Medical Advisory Committee will meet on Tuesday, September 12, 2023, and Wednesday, September 13, 2023, to review, discuss, deliberate, and formulate recommendations, as appropriate on the following topics. The Subcommittee on proposed Task Statement 23–X1—Directed Review of the Merchant Mariner Medical Manual will also meet on Day 1. Officer elections will be held on Day 2. DAY 1 The agenda for the September 12, 2023, virtual meeting is as follows: (1) The full Committee will meet briefly to discuss the Subcommittee Business and task statement, which is listed under paragraph (6) under Day 2 below. (2) The Subcommittee will then separately address and work on Task Statement 23–X1, Directed Review of the Merchant Mariner Medical Manual. (3) Report of the Subcommittee. At the end of the day, the Chair of the Subcommittee will report to the full Committee on what was accomplished. The full Committee will not take action on this date and the Subcommittee will present a full report to the Committee on Day 2 of the meeting. (4) Adjournment of meeting. DAY 2 The agenda for the September 13, 2023, virtual meeting is as follows: (1) Introduction. (2) Designated Federal Officer Remarks. (3) Remarks from U.S. Coast Guard Leadership. (4) Roll call of Committee members and determination of a quorum. (5) Election of Chair and Vice Chair. (5) Acceptance of Minutes from NMEDMAC Meeting 4. E:\FR\FM\16AUN1.SGM 16AUN1

Agencies

[Federal Register Volume 88, Number 157 (Wednesday, August 16, 2023)]
[Notices]
[Pages 55708-55709]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-17576]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the NIH Clinical Center 
Research Hospital Board.
    This will be a hybrid meeting held in-person and virtually and will 
be open to the public as indicated below. Individuals who plan to 
attend in-person or view the virtual meeting and need special 
assistance or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting. The meeting can 
be accessed from the NIH Videocast at the following link: https://videocast.nih.gov/.

    Name of Committee: NIH Clinical Center Research Hospital Board.
    Date: October 20, 2023.
    Time: 9:00 a.m. to 1:00 p.m.
    Agenda: NIH and Clinical Center (CC) Leadership Announcements, 
CC CEO Update of Recent Activities and Organizational Priorities, 
Status Report on Key CC Strategic Plan Initiatives, and Other 
Business of the Clinical Center Research Hospital Board (CCRHB).
    Place: National Institutes of Health, Building 31, Conference 
Room 6C02 A & B, 9000 Rockville Pike, Bethesda, MD 20892 (Hybrid 
Meeting).
    Contact Persons:
    Patricia Piringer, RN, MSN (C), National Institutes of Health 
Clinical Center, 10 Center Drive, Bethesda, MD 20892, 
[email protected], (301) 402-2435, (202) 460-7542 (direct).
    Natascha Pointer, Management Analyst, Executive Assistant to Dr. 
Gilman, Office of the Chief Executive Officer, National Institutes 
of Health Clinical Center, 10 Center Drive, Bethesda, MD 20892, 
[email protected], (301) 496-4114, (301) 402-2434 (direct).
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person(s) 
listed on this notice. The statement should include the name, 
address, telephone number and, when applicable, the business or 
professional affiliation of the interested person.
    In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for 
entrance into on-campus and off-campus facilities. All visitor 
vehicles, including taxicabs, hotel, and airport shuttles will be 
inspected before being allowed on campus. Visitors attending a 
meeting on campus or at an off-campus federal facility will be asked 
to show one form of identification (for example, a government-issued 
photo ID, driver's license, or passport) and to state the purpose of 
their visit.
    Information is also available on the CCRHB website: https://www.ccrhb.od.nih.gov/ where an agenda and any additional information 
for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research

[[Page 55709]]

Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH 
Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 
93.187, Undergraduate Scholarship Program for Individuals from 
Disadvantaged Backgrounds, National Institutes of Health, HHS)

    Dated: August 10, 2023.
Patricia B. Hansberger,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-17576 Filed 8-15-23; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.